Thomas W. Beetham's Net Worth

$8.01 Million

Estimate Recalculated Jun 7, 2024 03:54PM EST

Who is Thomas W. Beetham?

Thomas W. Beetham has an estimated net worth of $8.01 Million. This is based on reported shares across multiple companies, which include Kiniksa Pharmaceuticals, Ltd., Magenta Therapeutics, Inc., and Viridian Therapeutics, Inc.\DE.

SEC CIK

Thomas W. Beetham's CIK is 0001741382

Past Insider Trading and Trends

2021 was Thomas W. Beetham's most active year for acquiring shares with 7 total transactions. Thomas W. Beetham's most active month to acquire stocks was the month of February. 2020 was Thomas W. Beetham's most active year for disposing of shares, totalling 8 transactions. Thomas W. Beetham's most active month to dispose stocks was the month of January. 2018 saw Thomas W. Beetham paying a total of $99,995.17 for 105,956 shares, this is the most they've acquired in one year. In 2020 Thomas W. Beetham cashed out on 107,093 shares for a total of $2,050,511.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $18.22

EVP & Chief Legal Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Mar 20
Form 4
0
0
Mar 16
Form 4
297.52K
$22.09
-$54,716.93
297.52K
Scheduled
Feb 3
Form 4
0
0
Sep 10
Form 4
-100.00%
-29.59K
$25.37
-$750,678.08
0
Scheduled
Jul 1
Form 4
0
$13.33
-$322,896.96
29.59K
Scheduled
Jun 10
Form 4
-62.80%
-49.94K
$19.10
-$953,974.86
29.59K
Scheduled
Apr 20 - Apr 21
Form 4
0
0
Mar 13
Form 4
-0.07%
-59.00
$18.58
-$1,096.22
79.53K
Scheduled
Feb 14
Form 4
0
0
Sep 17
Form 4
0
0
Mar 4
Form 4
0
0
Sep 20
Form 4
+8.73%
6.39K
79.59K
Feb 9 - May 29
Form 3
0
0
No matching records found

Magenta Therapeutics, Inc. (DNTH) Snapshot price: $23.49

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+17.75%
3K
$0.94
$2,820.00
19.9K
Nov 30
Form 4
0
0
Aug 1
Form 4
+21.59%
3K
$0.99
$2,970.00
16.9K
May 31
Form 4
0
0
May 17
Form 4
0
0
Feb 15
Form 4
-30.51%
-6.10K
$6.73
-$41,073.19
13.9K
Sep 16
Form 4
20K
20K
Sep 14
Form 4
0
0
Jun 14
Form 3
0
0
No matching records found

Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $17.74

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
Form 4
0
0
Oct 30
No matching records found